Sporadic CRCs constitute a majority of the cancer cases, typically beginning with a mutation in the adenomatous polyposis coli (APC) gene, with subsequent mutations in KRAS, SMAD4, TP53 and DCC (10–12) (Figure 1). Here, APC is linked to cancer.